Home  /  R&D  /  Registration


Lixin Pharmaceutical has always been adhering to the global development strategy, and has already submitted 3 DMFs to FDA, obtained 3 CEP certificates, obtained 5 new drug certificates and 8 GMP certificates from NMPA. There are more than 20 products in progress as well. In addition, we have a large number of technical documents about related drug intermediates, and are always ready to provide support and services to our clients.